Pentacare CSM Day 1

Neuropathic pain is a type of pain caused by damage or dysfunction in the nervous system. It is known to have a significant impact on various aspects of a person's life. Higher psychological distress can occur as a result of the chronic pain, leading to increased anxiety, depression, and overall emotional distress. The pain can also disrupt sleep patterns, causing loss of sleep and further exacerbating the psychological distress. Additionally, the constant pain can interfere with daily activities and work productivity, resulting in a loss of work productivity. Ultimately, these factors contribute to a poor quality of life for individuals experiencing neuropathic pain.

The correct answer is "Based on PMPM". This means that the number of Laptop Overnight Bags to be given to doctors or ME (Medical Examiners) will be determined based on the PMPM (Per Member Per Month) metric. This suggests that the allocation of bags will depend on the number of members or patients each doctor or ME is responsible for on a monthly basis. The more members they have, the more bags they will receive.

Newcita has achieved the 8th rank as per IMS.

not-available-via-ai

The correct answer is "Both A & B" because Neurokem is a medication used to treat Trigeminal Neuralgia, which is a condition characterized by severe facial pain. It is also used to treat Post Herpatic Neuralgia, which is a type of nerve pain that occurs after a shingles infection. DPN, which stands for Diabetic Peripheral Neuropathy, is not mentioned as a diagnostic condition for Neurokem. Therefore, the correct answer is that Neurokem is used to treat both Trigeminal Neuralgia and Post Herpatic Neuralgia.

The correct answer is "All of the above". This means that all of the mentioned medications (Neurokem M, Neurokem NT, Neurokem OD, and Neurokem Plus) are targeted specialties for CPs. This implies that these medications are specifically designed or recommended for the treatment or management of CPs.

Based on the given options, the number of NEP PAIN UPDATE / ME planned is 25.

not-available-via-ai

The correct answer is Neurokem GP & Neurokem M. These two products are below target for the first quarter.

Pregastar M is a brand that belongs to the pharmaceutical company Lupin.

Pregator is a brand of Micro.

The given options of "Double the PMPM," "Minimum Targeted PMPM = 1 Lac," and "Prescribers Base of 25" are all objectives for Neurokem Gr. Therefore, the correct answer is "None of the above."

The Newcita Infographic LBL is scheduled to be distributed in August.

Lyrica is the correct answer because it is stated as the "Brand Leader" in the Pregabalin plain market. This implies that Lyrica is the leading brand in terms of sales, popularity, and market share for Pregabalin. The other options, Maxgalin, Pregabid, and Pregalin, are not specified as brand leaders, so they are not the correct answer.

LBLs (Labeling) are designed for brands like Newcita and Ceham. This means that both brands A (Newcita) and C (Ceham) have info graphic study LBLs.

The current rank of Neurkem NT in the Pregaba+ Nort Market as per IMS is 5.

The given answer states that "Patients with severe baseline pain experience greater improvement in both Pain relief and Sleep disturbance" is not a VA communication point for Neurokem M. This means that this particular statement is not a key point that the company wants to highlight when promoting Neurokem M. The other options, such as "Improves Nerve Conduction Velocity," "Promotes the regeneration of Injured Nerve," and "Inhibits Spontaneous Neuronal Discharge," are likely the key communication points for Neurokem M.

The expected ROI from BRAIN & ME doctors is 25K. This means that the return on investment for the doctors from BRAIN & ME is projected to be 25K, indicating that they can expect to earn a profit or gain of 25K from their investment in this particular venture.

The statement is false because there is no requirement for the targeted doctors to have a specific number of patients or to give a certain number of prescriptions during the neuropathy camp. The statement does not provide any criteria or guidelines for the number of patients or prescriptions. Therefore, it cannot be concluded that the targeted doctors should have 20-25 patients and give at least 15 prescriptions during the camp.

not-available-via-ai